Global Cardiovascular Therapeutics Market 2023-2027

Description

List of Tables

Technavio has been monitoring the cardiovascular therapeutics market and is forecast to grow by $37.77 bn during 2022-2027, accelerating at a CAGR of 7.32% during the forecast period. Our report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, the availability of advanced diagnostic methods, and the rising prevalence of hypercholesterolemia.

Technavio's cardiovascular therapeutics market is segmented as below:

By Type

Antithrombotic drugs
Hypolipidemic drugs
Others

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the advent of novel oral anticoagulants (NOACs) as one of the prime reasons driving the cardiovascular therapeutics market growth during the next few years. Also, the identification of new pathogenic targets and the strong incidence of coronary heart disease (CHD) will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cardiovascular therapeutics market covers the following areas:

Cardiovascular therapeutics market sizing
Cardiovascular therapeutics market forecast
Cardiovascular therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiovascular therapeutics market vendors that include Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc. Also, the cardiovascular therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR40101

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global cardiovascular therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global cardiovascular therapeutics market 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Antithrombotic drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
6.4 Hypolipidemic drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 60: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ billion)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 India - Market size and forecast 2022-2027
Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
9.10 Russia - Market size and forecast 2022-2027
Exhibit 99: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Russia - Year-over-year growth 2022-2027 (%)
9.11 Mexico - Market size and forecast 2022-2027
Exhibit 103: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key offerings
Exhibit 118: Abbott Laboratories - Segment focus
12.4 Astellas Pharma Inc.
Exhibit 119: Astellas Pharma Inc. - Overview
Exhibit 120: Astellas Pharma Inc. - Product / Service
Exhibit 121: Astellas Pharma Inc. - Key news
Exhibit 122: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 123: AstraZeneca Plc - Overview
Exhibit 124: AstraZeneca Plc - Product / Service
Exhibit 125: AstraZeneca Plc - Key news
Exhibit 126: AstraZeneca Plc - Key offerings
12.6 Aurobindo Pharma Ltd.
Exhibit 127: Aurobindo Pharma Ltd. - Overview
Exhibit 128: Aurobindo Pharma Ltd. - Product / Service
Exhibit 129: Aurobindo Pharma Ltd. - Key offerings
12.7 Bayer AG
Exhibit 130: Bayer AG - Overview
Exhibit 131: Bayer AG - Business segments
Exhibit 132: Bayer AG - Key news
Exhibit 133: Bayer AG - Key offerings
Exhibit 134: Bayer AG - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 135: Boehringer Ingelheim International GmbH - Overview
Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
Exhibit 137: Boehringer Ingelheim International GmbH - Key news
Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bristol Myers Squibb Co.
Exhibit 140: Bristol Myers Squibb Co. - Overview
Exhibit 141: Bristol Myers Squibb Co. - Product / Service
Exhibit 142: Bristol Myers Squibb Co. - Key news
Exhibit 143: Bristol Myers Squibb Co. - Key offerings
12.10 Daiichi Sankyo Co. Ltd.
Exhibit 144: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 145: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 146: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 148: Daiichi Sankyo Co. Ltd. - Segment focus
12.11 Dr Reddys Laboratories Ltd.
Exhibit 149: Dr Reddys Laboratories Ltd. - Overview
Exhibit 150: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 151: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 152: Dr Reddys Laboratories Ltd. - Segment focus
12.12 Eli Lilly and Co.
Exhibit 153: Eli Lilly and Co. - Overview
Exhibit 154: Eli Lilly and Co. - Product / Service
Exhibit 155: Eli Lilly and Co. - Key offerings
12.13 GlaxoSmithKline Plc
Exhibit 156: GlaxoSmithKline Plc - Overview
Exhibit 157: GlaxoSmithKline Plc - Business segments
Exhibit 158: GlaxoSmithKline Plc - Key news
Exhibit 159: GlaxoSmithKline Plc - Key offerings
Exhibit 160: GlaxoSmithKline Plc - Segment focus
12.14 Johnson and Johnson Services Inc.
Exhibit 161: Johnson and Johnson Services Inc. - Overview
Exhibit 162: Johnson and Johnson Services Inc. - Business segments
Exhibit 163: Johnson and Johnson Services Inc. - Key news
Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
12.15 Merck and Co. Inc.
Exhibit 166: Merck and Co. Inc. - Overview
Exhibit 167: Merck and Co. Inc. - Business segments
Exhibit 168: Merck and Co. Inc. - Key news
Exhibit 169: Merck and Co. Inc. - Key offerings
Exhibit 170: Merck and Co. Inc. - Segment focus
12.16 Pfizer Inc.
Exhibit 171: Pfizer Inc. - Overview
Exhibit 172: Pfizer Inc. - Product / Service
Exhibit 173: Pfizer Inc. - Key news
Exhibit 174: Pfizer Inc. - Key offerings
12.17 Viatris Inc.
Exhibit 175: Viatris Inc. - Overview
Exhibit 176: Viatris Inc. - Business segments
Exhibit 177: Viatris Inc. - Key offerings
Exhibit 178: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations